December 15, 2010 -- Shanghai Pharmaceuticals Holding Co. plans to spend 3.8 billion RMB ($570 million) to buy two China drug distribution-manufacturing companies. In one deal, Shanghai Pharma will pay 1.5 billion RMB ($225 million) for the antibiotics business of its parent company, Shanghai Pharmaceutical Group. And it finalized the terms on a previously announced transaction, acquiring 65% of China Health System (CHS) for 2.3 billion RMB ($345 million). More details....
